Jenna H Rannikko

5PUBLICATIONS
16CO-AUTHORS
MechanobiologyGene and molecular therapyTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 16, 2025
Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment.

Jenna H Rannikko, Rita Turpin, Pia Boström

|Jun 03, 2024
Clinical landscape of macrophage-reprogramming cancer immunotherapies.

Jenna H Rannikko, Maija Hollmén

|Nov 03, 2023
Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.

Jenna H Rannikko, Petri Bono, Johanna Hynninen

|May 02, 2022
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers.

Maija Hollmén, Mikael Maksimow, Jenna H Rannikko

|Jun 03, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala

Pageof 1

Frequent Collaborators

5 joint publications

Maija Hollmén

2 joint publications

Matti K Karvonen

2 joint publications

Petri Bono

1 joint publications

Reetta Virtakoivu